1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. TISSUE DIAGNOSTICS MARKET BY PRODUCT
5.1. Introduction
5.2. Consumables
5.2.1. Antibodies
5.2.2. Kits
5.2.3. Probes
5.2.4. Reagents
5.3. Instruments
5.3.1. Slide Scanners
5.3.2. Slide Staining System
5.3.3. Tissue Microarrays
5.3.4. Tissue Processing System
5.3.5. Others
6. TISSUE DIAGNOSTICS MARKET BY TECHNOLOGY
6.1. Introduction
6.2. Digital Pathology
6.3. Immunohistochemistry (IHC)
6.4. In Situ Hybridization (ISH)
6.5. Others
7. TISSUE DIAGNOSTICS MARKET BY APPLICATION
7.1. Introduction
7.2. Breast Cancer
7.3. Cervical Cancer
7.4. Colorectal Cancer
7.5. Gastric Cancer
7.6. Lung Cancer
7.7. Others
8. TISSUE DIAGNOSTICS MARKET BY END-USER
8.1. Introduction
8.2. Contract Research Organization (CRO)
8.3. Hospitals
8.4. Diagnostics Centers
8.5. Others
9. TISSUE DIAGNOSTICS MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. By Product
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End-User
9.2.5. By Country
9.2.5.1. USA
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. South America
9.3.1. By Product
9.3.2. By Technology
9.3.3. By Application
9.3.4. By End-User
9.3.5. By Country
9.3.5.1. Brazil
9.3.5.2. Argentina
9.3.5.3. Others
9.4. Europe
9.4.1. By Product
9.4.2. By Technology
9.4.3. By Application
9.4.4. By End-User
9.4.5. By Country
9.4.5.1. Germany
9.4.5.2. France
9.4.5.3. United Kingdom
9.4.5.4. Spain
9.4.5.5. Others
9.5. Middle East and Africa
9.5.1. By Product
9.5.2. By Technology
9.5.3. By Application
9.5.4. By End-User
9.5.5. By Country
9.5.5.1. Saudi Arabia
9.5.5.2. UAE
9.5.5.3. Others
9.6. Asia Pacific
9.6.1. By Product
9.6.2. By Technology
9.6.3. By Application
9.6.4. By End-User
9.6.5. By Country
9.6.5.1. China
9.6.5.2. India
9.6.5.3. Japan
9.6.5.4. South Korea
9.6.5.5. Indonesia
9.6.5.6. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Abbott Laboratories
11.2. Agilent Technologies, Inc.
11.3. Becton Dickinson
11.4. BioGenex
11.5. Cardinal Health
11.6. Danaher
11.7. F. Hoffmann-La Roche Ltd
11.8. Medtronic
11.9. Merck KgaA
11.10. Thermo Fisher Scientific Inc.
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations